R. S. Negm, M. Verma, and S. Srivastava, The promise of biomarkers in cancer screening and detection, Trends Mol Med, vol.8, pp.288-93, 2002.

C. L. Sawyers, The cancer biomarker problem, Nature, vol.452, pp.548-52, 2008.

L. J. Van't-veer and R. Bernards, Enabling personalized cancer medicine through analysis of geneexpression patterns, Nature, vol.452, pp.564-70, 2008.

A. Lievre, J. B. Bachet, V. Boige, A. Cayre, L. Corre et al., KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab, J Clin Oncol, vol.26, pp.374-383, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00363737

P. Laurent-puig, A. Cayre, G. Manceau, E. Buc, J. B. Bachet et al., Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer, J Clin Oncol, vol.27, pp.5924-5954, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00618089

A. Lievre, J. B. Bachet, L. Corre, D. Boige, V. Landi et al., KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer, Cancer Res, vol.66, pp.3992-3997, 2006.

A. D. Roth, S. Tejpar, M. Delorenzi, P. Yan, R. Fiocca et al., Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60 -00 trial, J Clin Oncol, vol.28, pp.466-74, 2010.

T. Lecomte, A. Berger, F. Zinzindohoue, S. Micard, B. Landi et al., Detection of freecirculating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis, Int J Cancer, vol.100, pp.542-550, 2002.

K. L. Aung, R. E. Board, G. Ellison, D. E. Ward, T. Clack et al., Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours, HUGO J, vol.4, pp.11-21, 2010.

H. Schwarzenbach, D. S. Hoon, and K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, vol.11, pp.426-463, 2011.

M. J. Higgins, D. Jelovac, E. Barnathan, B. Blair, S. Slater et al., Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood, Clin Cancer Res, vol.18, pp.3462-3471, 2012.

M. R. Stratton, Exploring the genomes of cancer cells: progress and promise, Science, vol.331, pp.1553-1561, 2011.

F. Diehl, K. Schmidt, M. A. Choti, K. Romans, S. Goodman et al., Circulating mutant DNA to assess tumor dynamics, Nat Med, vol.14, pp.985-90, 2008.

J. A. Ludwig and J. N. Weinstein, Biomarkers in cancer staging, prognosis and treatment selection, Nat Rev Cancer, vol.5, pp.845-56, 2005.

P. J. Sykes, S. H. Neoh, M. J. Brisco, E. Hughes, J. Condon et al., Quantitation of targets for PCR by use of limiting dilution, Biotechniques, vol.13, pp.444-453, 1992.

B. Vogelstein, K. W. Kinzler, and P. Digital, Proc Natl Acad Sci U S A, vol.96, pp.9236-9277, 1999.

M. Baker, Digital PCR hits its stride, Nat Methods, vol.9, pp.541-545, 2012.

V. Taly, D. Pekin, A. E. Abed, and P. Laurent-puig, Detecting biomarkers with microdroplet technology, Trends Mol Med, vol.18, pp.405-421, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02299585

D. Dressman, H. Yan, G. Traverso, K. W. Kinzler, and B. Vogelstein, Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations, Proc Natl Acad Sci U S A, vol.100, pp.8817-8839, 2003.

M. Nakano, J. Komatsu, S. Matsuura, K. Takashima, S. Katsura et al., Single-molecule PCR using water-in-oil emulsion, J Biotechnol, vol.102, pp.117-141, 2003.

A. B. Theberge, F. Courtois, Y. Schaerli, M. Fischlechner, C. Abell et al., Microdroplets in microfluidics: an evolving platform for discoveries in chemistry and biology, Angew Chem Int Ed Engl, vol.49, pp.5846-68, 2010.

D. Pekin, Y. Skhiri, J. C. Baret, L. Corre, D. Mazutis et al., Quantitative and sensitive detection of rare mutations using droplet-based microfluidics, Lab Chip, vol.11, pp.2156-66, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02148770

B. J. Hindson, K. D. Ness, D. A. Masquelier, P. Belgrader, N. J. Heredia et al., Highthroughput droplet digital PCR system for absolute quantitation of DNA copy number, Anal Chem, vol.83, pp.8604-8614, 2011.

L. B. Pinheiro, V. A. Coleman, C. M. Hindson, J. Herrmann, B. J. Hindson et al., Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification, Anal Chem, vol.84, pp.1003-1014, 2012.

A. C. Hatch, J. S. Fisher, A. R. Tovar, A. T. Hsieh, R. Lin et al., 1-Million droplet array with wide-field fluorescence imaging for digital PCR, Lab Chip, vol.11, pp.3838-3883, 2011.

Q. Zhong, S. Bhattacharya, S. Kotsopoulos, J. Olson, V. Taly et al., Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR, Lab Chip, vol.11, pp.2167-74, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02299588

A. Russo, V. Bazan, A. V. Rodolico, V. Gebbia, and N. , Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies, Ann Oncol, vol.16, issue.4, pp.44-53, 2005.

A. Didelot, L. Corre, D. Luscan, A. Cazes, A. Pallier et al., Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples, Exp Mol Pathol, vol.92, pp.275-80, 2012.

A. M. Garvin, M. Bottinelli, M. Gola, A. Conti, and G. Soldati, DNA preparation from sexual assault cases by selective degradation of contaminating DNA from the victim, J Forensic Sci, vol.54, pp.1297-303, 2009.

A. Didelot, S. K. Kotsopoulos, A. Lupo, D. Pekin, X. Li et al., Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples, Clin Chem, vol.59, pp.815-838, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02299583

E. Gormally, E. Caboux, P. Vineis, and P. Hainaut, Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance, Mutat Res, vol.635, pp.105-122, 2007.

K. L. Spindler, N. Pallisgaard, I. Vogelius, and A. Jakobsen, Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012.

K. Taniguchi, J. Uchida, K. Nishino, T. Kumagai, T. Okuyama et al., Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas, Clin Cancer Res, vol.17, pp.7808-7823, 2011.

N. Knijn, L. J. Mekenkamp, M. Klomp, M. E. Vink-borger, J. Tol et al., KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients, Br J Cancer, vol.104, pp.1020-1026, 2011.

D. Santini, F. Loupakis, B. Vincenzi, I. Floriani, I. Stasi et al., High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice, Oncologist, vol.13, pp.1270-1275, 2008.

A. Szpechcinski, R. Struniawska, J. Zaleska, M. Chabowski, T. Orlowski et al., Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients, J Physiol Pharmacol, vol.59, issue.6, pp.675-81, 2008.

I. Bozic, B. Allen, and M. A. Nowak, Dynamics of targeted cancer therapy, Trends Mol Med, vol.18, pp.311-317, 2012.

S. E. Yost, E. N. Smith, R. B. Schwab, L. Bao, H. Jung et al., Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens, Nucleic Acids Res, vol.40, p.107, 2012.

A. L. Richardson and J. D. Iglehart, BEAMing up personalized medicine: mutation detection in blood, Clin Cancer Res, vol.18, pp.3209-3220, 2012.

L. A. Diaz, R. T. Williams, J. Wu, I. Kinde, J. R. Hecht et al., The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers, Nature, vol.486, pp.537-577, 2012.